Literature DB >> 8556820

Clinical phenotype associated with terminal 2q37 deletion.

B Conrad1, G Dewald, E Christensen, M Lopez, J Higgins, M E Pierpont.   

Abstract

Three children with deletions of the terminal portion of the long arm of chromosome 2 [del (2) (q37)] are described and their clinical findings compared to published cases of 2q terminal deletions. Common clinical findings include development delay, macrocephaly, frontal bossing, depressed nasal bridge and cardiac anomaly. Hypotonia and repetitive behavior are also seen during different times of development. The facial characteristics of children with 2q terminal deletions are not uniform, but development delay is a constant finding. Chromosomal analysis of such children using high resolution banding may uncover the diagnosis of a small chromosomal deletion.

Entities:  

Mesh:

Year:  1995        PMID: 8556820     DOI: 10.1111/j.1399-0004.1995.tb04073.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.

Authors:  A H Wang; N R Bertos; M Vezmar; N Pelletier; M Crosato; H H Heng; J Th'ng; J Han; X J Yang
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37.

Authors:  M M Power; R S James; J C Barber; A M Fisher; P J Wood; B A Leatherdale; D E Flanagan; E Hatchwell
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

4.  Paracentric inversion of chromosome 2 associated with cryptic duplication of 2q14 and deletion of 2q37 in a patient with autism.

Authors:  Françoise Devillard; Vincent Guinchat; Daniel Moreno-De-Luca; Anne-Claude Tabet; Nicolas Gruchy; Pascale Guillem; Marie-Ange Nguyen Morel; Nathalie Leporrier; Marion Leboyer; Pierre-Simon Jouk; James Lespinasse; Catalina Betancur
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

Review 5.  Deletion of chromosome 2q37 and autism: a distinct subtype?

Authors:  M Ghaziuddin; M Burmeister
Journal:  J Autism Dev Disord       Date:  1999-06

Review 6.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

7.  Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice.

Authors:  Natalia T Leach; Yi Sun; Sebastien Michaud; Yi Zheng; Keith L Ligon; Azra H Ligon; Thomas Sander; Bruce R Korf; Weining Lu; David J Harris; James F Gusella; Richard L Maas; Bradley J Quade; Andrew J Cole; Max B Kelz; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2007-02-12       Impact factor: 11.025

8.  Brief report: peculiar evolution of autistic behaviors in two unrelated children with brachidactyly-mental retardation syndrome.

Authors:  Luigi Mazzone; Lia Vassena; Liliana Ruta; Diego Mugno; Ornella Galesi; Marco Fichera
Journal:  J Autism Dev Disord       Date:  2012-10

9.  A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation.

Authors:  I Borg; M Squire; C Menzel; K Stout; D Morgan; L Willatt; P C M O'Brien; M A Ferguson-Smith; H H Ropers; N Tommerup; V M Kalscheuer; D R Sargan
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

10.  Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.

Authors:  Kylie M Drake; E Cristy Ruteshouser; Rachael Natrajan; Phyllis Harbor; Jenny Wegert; Manfred Gessler; Kathy Pritchard-Jones; Paul Grundy; Jeffrey Dome; Vicki Huff; Chris Jones; Micheala A Aldred
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.